Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-947-7 | CAS number: 1458-18-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- January 14 - January 21, 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- (2010)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- Version / remarks:
- (2009)
- Deviations:
- no
- GLP compliance:
- yes
- Species:
- human
- Details on test animals or test system and environmental conditions:
- ENVIRONMENTAL CONDITIONS
- Temperature (°C): 36.8 - 37.4
- Humidity (%): 79 - 96 - Vehicle:
- unchanged (no vehicle)
- Amount / concentration applied:
- TEST MATERIAL
- Amounts applied: 11.7 to 14.2 mg, 5 μl Milli-Q water to moisten skin.
NEGATIVE CONTOL:
- Amount applied: 25 µl Phosphate buffered saline
POSITIVE CONTROL
- Amount applied: 25 µl
- Concentration: 5% (aq) Sodium dodecyl sulphate - Duration of treatment / exposure:
- 15 minutes
- Details on study design:
- TEST SITE
- EPISKIN Small ModelTM(EPISKIN-SMTM, 0.38 cm2, Lot no.: 13-EKIN-001).This model is a three-dimensional human epidermis model, which consists of adult human-derived epidermal keratinocytes which have been seeded in 12-well plates on a dermal substitute consisting of a collagen type I matrix coated with type IV collagen. The keratinocytes were cultured for 13 days , which results in a highly differentiated and stratified epidermis model comprising the main basal, supra basal, spinous and granular layers and a functional stratum corneum.
REMOVAL OF TEST SUBSTANCE
- Washing: phosphate buffered saline
- Time after start of exposure: 15 minutes
POST INCUBATION PERIOD
- 42 hours
SCORING SYSTEM:
- Cytotoxicity is expressed as the reduction of mitochondrial dehydrogenase activity measured by formazan production from MTT at the end of the treatment. Cell viability was calculated for each tissue as a percentage of the mean of the negative control tissues. - Irritation / corrosion parameter:
- % tissue viability
- Value:
- 77
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: Percentage of control. Time point: 15 minutes. Remarks: Negative control = 100%; Positive control = 5%.
- Other effects / acceptance of results:
- Skin irritation is expressed as the remaining cell viability after exposure to the test substance.
The relative mean tissue viability obtained after 15 minutes treatment with Amiloride Compound 7 compared to the negative control tissues was 77%. Since the mean relative tissue viability for Amiloride Compound 7 was above 50% Amiloride Compound 7 is considered to be non-irritant. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- The in vitro skin irritation test was conducted according to OECD 439 guideline and GLP principles.
It is concluded that this test is valid and that Amiloride Compound 7 is not irritating in the in vitro skin irritation test. - Executive summary:
In an in vitro skin irritation test using a human skin model ( EPISKIN Standard Model), the influence of Amiloride Compound 7 on the viability of human skin was tested. The test substance was applied directly to 0.38 cm2 cultured skin (11.7 to 14.2 mg, in presence of 5 μl Milli-Q water). After 15 minutes, the substance was removed and cells were cultured for 42 hours. The viability of the cells was tested by reduction of MTT. Survival of unexposed skin was set at 100%, the positive control had a mean cell viability of 5% whereas the test substance showed cell viability of 77%. Since the mean relative tissue viability after exposure to the test substance was above 50%, it can be concluded that Amiloride Compound 7 is not irritating in the in vitro skin irritation test.
Reference
The test substance was checked for possible direct MTT reduction by adding the test substance to MTT medium. Because no colour change was observed it was concluded that the test substance did not interact with MTT.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation, other
- Remarks:
- other: expert judgement
- Type of information:
- other: expert judgement
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Principles of method if other than guideline:
- Combination of BCOP assay result for the substance in question and abbeviated results froman in vivo study conducted pre-guideline and GLP.
- Species:
- rabbit
- Vehicle:
- physiological saline
- Amount / concentration applied:
- 0.1 ml at 10 %
- Observation period (in vivo):
- 96 hours
- Number of animals or in vitro replicates:
- 4
- Irritation parameter:
- other: qualitative
- Basis:
- mean
- Time point:
- other: 96 hrs.
- Score:
- ca. 0
- Reversibility:
- fully reversible within: 96 hrs.
- Remarks on result:
- not determinable because of methodological limitations
- Irritant / corrosive response data:
Amiloride 7 BCOP in vitro score 1.4- not a severe eye irritant.
In vivo: dated 15 March 1965
Species: rabbit
No tested: 4
Instillation: 0.1ml at 10% concentration in saline
Results: Produced apparent "stinging, slight injection of the conjunctivae, chemosis and discharge persisting through 24 hours. The eyes were normal whenexamined at 96 hours.- Interpretation of results:
- not irritating
- Remarks:
- Migrated information Criteria used for interpretation of results: expert judgment
- Conclusions:
- The results from the BCOP assay conducted would indicate that the substance is not classified for serious eye damage, in addition the minimal in vitro score would indicate that the substance would have negligible effects on the ocular tissue in vivo. The results from the in vivo study, while not sufficient in themselves to make a conclusive decision on classification, in combination with the BCOP results indicate that the substance is none irritant.
- Executive summary:
A weight of evidence determination has been carried out to assess the eye irritation potential of Amiloride 7, based upon the results of the in vitro BCOP assay and historical in vivo data. The results of the BCOP assay are overwhelmingly negative, while the observations in 4 rabbits with no corneal or iris involvement and only minimal conjunctival involvement which resolve by 96 hours indicate that the substance is not a serious eye irritant and would not fulfill the EU CLP critieria for classification.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for selection of skin irritation / corrosion endpoint:
A modern study in accordance with EU Method B46, conducted to GLP
Justification for selection of eye irritation endpoint:
A weight of evidence determination drawing information from a modern GLP study conducted to an EU Method and historical in vivo studies, to derive a robust classification.
Justification for classification or non-classification
Skin Irritation:
Survival of unexposed skin was set at 100%, the positive control had a mean cell viability of 5% whereas the test substance showed cell viability of 77%. Since the mean relative tissue viability after exposure to the test substance was above 50%, it can be concluded that Amiloride Compound 7 is not irritating in the in vitro skin irritation test. The in vitro skin irritation test was conducted according to OECD 439 guideline and GLP principles. It is concluded that this test is valid and that Amiloride Compound 7 is not irritating in the in vitro skin irritation test.
Eye Irritation:
A weight of evidence determination has been carried out to assess the eye irritation potential of Amiloride 7, based upon the results of the in vitro BCOP assay and historical in vivo data. The results of the BCOP assay are overwhelmingly negative, while the observations in 4 rabbits with no corneal or iris involvement and only minimal conjunctival involvement which resolve by 96 hours indicate that the substance is not a serious eye irritant and would not fulfill the EU CLP critieria for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.